AViTA Corporation (4735) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of AViTA Corporation stock TWD 21.07, price TWD 35.10, that is 40.0% below the price, quality 51 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 27.20 TWD – 65.56 TWD · fair‑value band 19.24 TWD – 24.43 TWD · the 35.10 TWD price screens above the 21.07 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow AViTA in your weekly email
Every Wednesday you see whether AViTA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products.
Show moreShow less
Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb.
AViTA Corporation was founded in 1996 and is headquartered in New Taipei City, Taiwan.
Stock analysis
AViTA Corporation (4735) currently trades at 35.10 TWD, while our model-based Fair Value estimate is 21.07 TWD, 40% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 44.88 TWD per share, and 5 of the 14 models we run sit above the 35.10 TWD price.
Bear case: the Asset-Based group reads lowest at 8.23 TWD, and 9 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 19.24 TWD (bear) to 24.43 TWD (bull), the price of 35.10 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
AViTA Corporation reported revenue of 936M TWD in FY2025 versus 2.3B TWD in FY2021, a compound −20.3%/yr. Reported net income was 93.2M TWD in FY2025, compounding −26.3%/yr from FY2021.
Key figures
Market cap 1.4B TWD (≈ $41.2M) Micro · P/E ratio 5.9 · P/S ratio 1.39 · EPS (TTM) 6.00 TWD · Dividend yield 1.7% · Net margin 23.8% · Return on equity 22.6% · Return on assets (EBIT) 8.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (low confidence).
What moves the price
The share trades about 12% below its 52-week high and 19% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at −40%, 4735 screens richer than that median.
Fair Value models
Bear19.24 TWDFair Value 21.07 TWDBull24.43 TWD
Price 35.10 TWD · Downside -40.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (4.64 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income22.63 TWD24.79 TWD28.74 TWD76
EPV17.27 TWD18.99 TWD20.49 TWD74
ROIC Compounder17.27 TWD18.99 TWD20.49 TWD72
All 14 models by family
Earnings-Based
Graham-Dodd16.46 TWD20.11 TWD22.63 TWD67
EPV17.27 TWD18.99 TWD20.49 TWD74
Dividend Discount
Gordon GGM21.38 TWD23.41 TWD26.49 TWD69
DDM Multi-Stage21.38 TWD26.83 TWD34.48 TWD67
Multiples
P/E Multiple39.93 TWD53.24 TWD66.55 TWD63
P/S Multiple30.86 TWD41.14 TWD51.43 TWD58
P/B Multiple43.79 TWD58.38 TWD72.98 TWD55
EV/EBIT25.17 TWD30.29 TWD35.40 TWD66
EV/EBITDA38.92 TWD48.62 TWD58.33 TWD67
EV/Revenue20.77 TWD25.47 TWD30.17 TWD54
Asset-Based
NCAV (Graham)5.43 TWD8.23 TWD10.28 TWD55
Economic Profit
Residual Income22.63 TWD24.79 TWD28.74 TWD76
ROIC Compounder17.27 TWD18.99 TWD20.49 TWD72
Growth Earnings
Growth-Adj P/E28.15 TWD40.21 TWD52.28 TWD67
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.24/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+1.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.5%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.4%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−33.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−35.6%
Dividend (yield on the price)1.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 5%
⚠ Revenue per share shrinking 6.9%/yr over ~6Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 318 stocks
Beats the industry median on 9/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score51 · Below median
Fair Value upside−40.0% · Below median
Profitability
Return on equity (12 months)22.6% · Top 25%
Return on assets6.9% · Top 25%
Net margin (12 months)23.8% · Top 25%
Operating margin (12 months)10.4% · Above median
Growth and dividend
Revenue growth (quarter YoY)7.8% · Above median
Dividend yield (12 months)1.7% · Below median
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (12 months)5.9× · Cheapest 25%
P/B1.36× · Cheaper than median
P/S (12 months)1.39× · Cheapest 25%
EV/EBITDA10.4× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 6
FUTURE (revenue growth)39· sector 36
PAST (return on equity)91· sector 17
HEALTH (low debt)100· sector 98
DIVIDEND (yield)34· sector 34
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "AViTA Corporation Fair Value". https://www.fairvalue-calculator.com/stock/4735
Frequently asked questions
Is AViTA Corporation (4735) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 21.07 TWD versus a price of 35.10 TWD, about 40% lower (overvalued).
What is the fair value of 4735?
Our model-based fair value for AViTA Corporation is 21.07 TWD (as of Nov 9, 2026), built from audited fundamentals. The current price: 35.10 TWD.
What is the quality score of 4735?
AViTA Corporation has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for AViTA Corporation (4735)?
Our model-based price target is the fair value of 21.07 TWD (as of Nov 9, 2026) from 14 valuation models. Cautious scenario 19.24 TWD, optimistic scenario 24.43 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the AViTA Corporation stock forecast for 2026?
Our models put fair value at 21.07 TWD, about 40% lower versus a price of 35.10 TWD (overvalued). Cautious scenario 19.24 TWD, optimistic scenario 24.43 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of AViTA Corporation (4735)?
AViTA Corporation reported trailing-twelve-month revenue of about 973M TWD (latest available figure, as of Nov 9, 2026).
Does AViTA Corporation pay a dividend?
AViTA Corporation currently shows a dividend yield of 1.69% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of AViTA Corporation (4735) and when is the ex-dividend date?
AViTA Corporation pays a dividend of 0.592 TWD per share a year, a dividend yield of 1.7%. The last ex-dividend date was Aug 31, 2026. A dividend has been paid every year since at least 2015. The payout ratio is 9.9% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of AViTA Corporation (4735)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For AViTA Corporation it is 21.07 TWD per share (as of Nov 9, 2026), against a price of 35.10 TWD. It is the blended result of 14 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is AViTA Corporation stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 4735 trades above its calculated fair value: price 35.10 TWD, fair value 21.07 TWD, a gap of about −40% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4735?
No. The price is what the market pays today (35.10 TWD); the fair value is what the company's own numbers justify (21.07 TWD). For AViTA Corporation the two are 14.03 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is AViTA Corporation worth?
The market values AViTA Corporation at about 1.4B TWD (market capitalisation, as of Nov 9, 2026). Per share that is 35.10 TWD; our models calculate a fair value of 21.07 TWD per share.
What do the bullish and bearish scenarios say about 4735?
Our models span a range for AViTA Corporation: cautious scenario 19.24 TWD, base 21.07 TWD, optimistic 24.43 TWD per share (as of Nov 9, 2026, price 35.10 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4735?
AViTA Corporation trades at a price-to-earnings ratio of 5.9 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 21.07 TWD is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings: 13.3. Other multiples: P/B 1.4, P/S 1.4, EV/EBITDA 10.4.
How solid is the balance sheet of AViTA Corporation (4735)?
Balance-sheet figures for AViTA Corporation (as of Nov 9, 2026): return on equity 22.6%. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 4735 from its 52-week high?
AViTA Corporation trades at 35.10 TWD, about 12% below its 52-week high of 39.75 TWD and 19% above the low of 29.50 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 21.07 TWD is for.
Which stocks are comparable to AViTA Corporation?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is AViTA Corporation stock attractive at the current price?
The data as of Nov 9, 2026: price 35.10 TWD, calculated fair value 21.07 TWD (−40%), Quality Score 51/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4735 calculated?
We run AViTA Corporation through 14 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 21.07 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. AViTA Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of AViTA Corporation (4735)?
The closing price on Nov 6, 2026 was 35.10 TWD. Our model-based fair value is 21.07 TWD, about 40% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with AViTA Corporation right now?
The price sits above even our optimistic bull case (24.43 TWD). The favourable scenario is already priced in. Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of AViTA Corporation
How large is the market capitalisation of AViTA Corporation (4735)?
The market capitalisation of AViTA Corporation is 1.4B TWD (≈ $41.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of AViTA Corporation (4735)?
The price-to-sales ratio of AViTA Corporation is 1.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of AViTA Corporation (4735)?
Earnings per share at AViTA Corporation are 6.00 TWD (price ÷ EPS = P/E 5.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of AViTA Corporation (4735)?
The dividend yield of AViTA Corporation is 1.7% (payout 9.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of AViTA Corporation (4735)?
The net margin of AViTA Corporation is 23.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of AViTA Corporation (4735)?
The return on equity (ROE) of AViTA Corporation is 22.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of AViTA Corporation (4735)?
On an EBIT basis the return on assets of AViTA Corporation is 8.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of AViTA Corporation (4735)?
The operating margin of AViTA Corporation is 10.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at AViTA Corporation (4735)?
Revenue at AViTA Corporation is growing +7.8% versus a year earlier (3y avg −8.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at AViTA Corporation (4735)?
Earnings per share at AViTA Corporation are growing +528% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does AViTA Corporation (4735) generate?
The free cash flow of AViTA Corporation is −198M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does AViTA Corporation (4735) hold?
AViTA Corporation holds more cash than debt, 378M TWD net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch AViTA Corporation in the live analysis
One click puts AViTA Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 9, 2026